A novel therapy for genital herpes engages immune cells to provide significant patient benefits
A phase II clinical trial demonstrated that a new type of treatment for genital herpes, an immunotherapy called GEN-003, may reduce the activity of the virus and the number of days with recurrent herpes. This effect of treatment, ...
Jun 20, 2016
0
8